Merit Medical Systems, Inc. $MMSI Holdings Boosted by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. raised its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 972.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 211,891 shares of the medical instruments supplier’s stock after buying an additional 192,141 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Merit Medical Systems were worth $18,676,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Salomon & Ludwin LLC bought a new stake in shares of Merit Medical Systems in the 3rd quarter worth approximately $37,000. Danske Bank A S acquired a new position in Merit Medical Systems during the 3rd quarter valued at approximately $42,000. Quarry LP grew its stake in Merit Medical Systems by 185.9% during the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock worth $44,000 after buying an additional 342 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in Merit Medical Systems by 745.9% in the second quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock worth $86,000 after buying an additional 813 shares during the period. Finally, First Horizon Corp acquired a new stake in Merit Medical Systems in the third quarter worth $78,000. 99.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

MMSI has been the topic of a number of recent research reports. Piper Sandler cut their target price on Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 18th. Wells Fargo & Company cut shares of Merit Medical Systems from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $95.00 to $78.00 in a report on Thursday, February 26th. Needham & Company LLC cut their price objective on shares of Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating on the stock in a research report on Wednesday, February 25th. Barrington Research boosted their target price on shares of Merit Medical Systems from $106.00 to $109.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Finally, Robert W. Baird set a $108.00 target price on shares of Merit Medical Systems in a research report on Tuesday, December 16th. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $103.33.

Merit Medical Systems Stock Up 1.8%

Shares of Merit Medical Systems stock opened at $69.31 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.34 and a quick ratio of 2.95. Merit Medical Systems, Inc. has a 1-year low of $66.34 and a 1-year high of $107.27. The business’s fifty day moving average price is $77.12 and its two-hundred day moving average price is $82.44. The company has a market capitalization of $4.12 billion, a P/E ratio of 32.69, a PEG ratio of 1.96 and a beta of 0.62.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.08. The company had revenue of $393.94 million during the quarter, compared to analysts’ expectations of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The company’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.93 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, research analysts forecast that Merit Medical Systems, Inc. will post 3.37 EPS for the current year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.